Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
November-2022 Volume 26 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2022 Volume 26 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data1.pdf
    • Supplementary_Data2.pdf
Article Open Access

Downregulation of deubiquitinating enzyme USP25 promotes the development of allergic rhinitis by enhancing TSLP signaling in the nasal epithelium

  • Authors:
    • Wenchuan Chang
    • Hao Lv
    • Lu Tan
    • Ziang Gao
    • Peiqiang Liu
    • Danxue Qin
    • Wei Zhang
    • Yu Xu
  • View Affiliations / Copyright

    Affiliations: Department of Otolaryngology‑Head and Neck Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China
    Copyright: © Chang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 347
    |
    Published online on: September 28, 2022
       https://doi.org/10.3892/mmr.2022.12863
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Ubiquitin‑specific peptidase 25 (USP25) is a key deubiquitylase belonging to the USP superfamily that is primarily involved in inflammation and the immune response. Thymic stromal lymphopoietin (TSLP) is an epithelial‑derived cytokine that is regarded as the master switch that initiates and maintains the type 2 immune response in allergic rhinitis (AR). However, the molecular mechanisms by which USP25 regulates TSLP signaling in the nasal epithelium in AR remain unclear. The present study assessed the protein expression levels of USP25 in the nasal epithelium of patients with AR. Moreover, USP25 knockout (KO) and wild‑type (WT) mice were treated with ovalbumin (OVA) to establish a model of AR. The results of western blotting and immunohistochemistry in the present study demonstrated that the protein expression levels of USP25 were significantly decreased in the nasal mucosa of patients with AR and AR mice, whereas the protein expression levels of TSLP were significantly increased. Allergic inflammation was more severe in USP25 KO mice compared with WT mice exposed to OVA, as demonstrated by increased nose scratching and sneezing, increased eosinophil infiltration, goblet cell hyperplasia and enhanced T helper type 2 (Th2) cytokine production. The results of in vitro experiments demonstrated that silencing or overexpression of USP25 decreased or increased TNF receptor‑associated factor 3 (TRAF3) protein expression levels, respectively, in human nasal epithelial cells, whereas TSLP protein expression levels were negatively associated with the expression of USP25 and TRAF3. In summary, USP25 downregulation enhanced TSLP signaling in the nasal mucosal epithelium via decreased TRAF3 expression, thereby exacerbating inflammation in AR. Therefore, USP25 may act as a novel therapeutic target in AR.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Vandenplas O, Vinnikov D, Blanc PD, Agache I, Bachert C, Bewick M, Cardell LO, Cullinan P, Demoly P, Descatha A, et al: Impact of rhinitis on work productivity: A systematic review. J Allergy Clin Immunol Pract. 6:1274–1286.e9. 2018. View Article : Google Scholar : PubMed/NCBI

2 

Brożek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S, Brignardello-Petersen R, Canonica GW, Casale T, Chavannes NH, et al: Allergic rhinitis and its impact on asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 140:950–958. 2017. View Article : Google Scholar : PubMed/NCBI

3 

Zhang Y and Zhang L: Increasing prevalence of allergic rhinitis in China, allergy. Asthma Immunol Res. 11:156–169. 2019. View Article : Google Scholar : PubMed/NCBI

4 

Savouré M, Bousquet J, Jaakkola JJK, Jaakkola MS, Jacquemin B and Nadif R: Worldwide prevalence of rhinitis in adults: A review of definitions and temporal evolution. Clin Transl Allergy. 12:e121302022. View Article : Google Scholar : PubMed/NCBI

5 

Sozańska B, Błaszczyk M, Pearce N and Cullinan P: Atopy and allergic respiratory disease in rural Poland before and after accession to the European union. J Allergy Clin Immunol. 133:1347–1353. 2014. View Article : Google Scholar : PubMed/NCBI

6 

Wang XD, Zheng M, Lou HF, Wang CS, Zhang Y, Bo MY, Ge SQ, Zhang N, Zhang L and Bachert C: An increased prevalence of self-reported allergic rhinitis in major Chinese cities from 2005 to 2011. Allergy. 71:1170–1180. 2016. View Article : Google Scholar : PubMed/NCBI

7 

Myong JP, Kim H, Lee K and Chang S: Time trends of allergic rhinitis and effects of residence on allergic rhinitis in Korea from 1998 through 2007–2009. Asian Nurs Res (Korean Soc Nurs Sci). 6:102–106. 2012.PubMed/NCBI

8 

Ha J, Lee SW and Yon DK: Ten-year trends and prevalence of asthma, allergic rhinitis, and atopic dermatitis among the Korean population, 2008–2017. Clin Exp Pediatr. 63:278–283. 2020. View Article : Google Scholar : PubMed/NCBI

9 

Ordovas-Montanes J, Dwyer DF, Nyquist SK, Buchheit KM, Vukovic M, Deb C, Wadsworth MH II, Hughes TK, Kazer SW, Yoshimoto E, et al: Allergic inflammatory memory in human respiratory epithelial progenitor cells. Nature. 560:649–654. 2018. View Article : Google Scholar : PubMed/NCBI

10 

Krohn IK, Seys SF, Lund G, Jonckheere AC, de Casterlé ID, Ceuppens JL, Steelant B and Hellings PW: Nasal epithelial barrier dysfunction increases sensitization and mast cell degranulation in the absence of allergic inflammation. Allergy. 75:1155–1164. 2020. View Article : Google Scholar : PubMed/NCBI

11 

Bergougnan C, Dittlein DC, Hümmer E, Riepl R, Eisenbart S, Böck D, Griesbaum L, Weigl A, Damialis A, Hartwig A, et al: Physical and immunological barrier of human primary nasal epithelial cells from non-allergic and allergic donors. World Allergy Organ J. 13:1001092020. View Article : Google Scholar : PubMed/NCBI

12 

Park JY, Choi JH, Lee SN, Cho HJ, Ahn JS, Kim YB, Park DY, Park SC, Kim SI, Kang MJ, et al: Protein arginine methyltransferase 1 contributes to the development of allergic rhinitis by promoting the production of epithelial-derived cytokines. J Allergy Clin Immunol. 147:1720–1731. 2021. View Article : Google Scholar : PubMed/NCBI

13 

Wang WW, Zhu K, Yu HW and Pan YL: Interleukin-17A potentiates interleukin-13-induced eotaxin-3 production by human nasal epithelial cells from patients with allergic rhinitis. Int Forum Allergy Rhinol. 9:1327–1333. 2019. View Article : Google Scholar : PubMed/NCBI

14 

Marković I and Savvides SN: Modulation of signaling mediated by TSLP and IL-7 in inflammation, autoimmune diseases, and cancer. Front Immunol. 11:15572020. View Article : Google Scholar : PubMed/NCBI

15 

Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, Gilliet M, Ho S, Antonenko S, Lauerma A, et al: Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol. 3:673–680. 2002. View Article : Google Scholar : PubMed/NCBI

16 

Hammad H and Lambrecht BN: Barrier epithelial cells and the control of type 2 immunity. Immunity. 43:29–40. 2015. View Article : Google Scholar : PubMed/NCBI

17 

Toki S, Goleniewska K, Zhang J, Zhou W, Newcomb DC, Zhou B, Kita H, Boyd KL and Peebles RS Jr: TSLP and IL-33 reciprocally promote each other's lung protein expression and ILC2 receptor expression to enhance innate type-2 airway inflammation. Allergy. 75:1606–1617. 2020. View Article : Google Scholar : PubMed/NCBI

18 

Takai T: TSLP expression: Cellular sources, triggers, and regulatory mechanisms. Allergol Int. 61:3–17. 2012. View Article : Google Scholar : PubMed/NCBI

19 

Meng P, Chen ZG, Zhang TT, Liang ZZ, Zou XL, Yang HL and Li HT: IL-37 alleviates house dust mite-induced chronic allergic asthma by targeting TSLP through the NF-κB and ERK1/2 signaling pathways. Immunol Cell Biol. 97:403–415. 2019. View Article : Google Scholar : PubMed/NCBI

20 

Kuroda Y, Yuki T, Takahashi Y, Sakaguchi H, Matsunaga K and Itagaki H: An acid-hydrolyzed wheat protein activates the inflammatory and NF-κB pathways leading to long TSLP transcription in human keratinocytes. J Toxicol Sci. 45:327–337. 2020. View Article : Google Scholar : PubMed/NCBI

21 

Song L and Luo ZQ: Post-translational regulation of ubiquitin signaling. J Cell Biol. 218:1776–1786. 2019. View Article : Google Scholar : PubMed/NCBI

22 

Budroni V and Versteeg GA: Negative regulation of the innate immune response through proteasomal degradation and deubiquitination. Viruses. 13:5842021. View Article : Google Scholar : PubMed/NCBI

23 

Georges A, Gros P and Fodil N: USP15: A review of its implication in immune and inflammatory processes and tumor progression. Genes Immun. 22:12–23. 2021. View Article : Google Scholar : PubMed/NCBI

24 

Ren Y, Zhao Y, Lin D, Xu X, Zhu Q, Yao J, Shu HB and Zhong B: The type I interferon-IRF7 axis mediates transcriptional expression of Usp25 gene. J Biol Chem. 291:13206–13215. 2016. View Article : Google Scholar : PubMed/NCBI

25 

Long C, Lai Y, Li J, Huang J and Zou C: LPS promotes HBO1 stability via USP25 to modulate inflammatory gene transcription in THP-1 cells. Biochim Biophys Acta Gene Regul Mech. 1861:773–782. 2018. View Article : Google Scholar : PubMed/NCBI

26 

Zhong B, Liu X, Wang X, Liu X, Li H, Darnay BG, Lin X, Sun SC and Dong C: Ubiquitin-specific protease 25 regulates TLR4-dependent innate immune responses through deubiquitination of the adaptor protein TRAF3. Sci Signal. 6:ra352013. View Article : Google Scholar : PubMed/NCBI

27 

Lin D, Zhang M, Zhang MX, Ren Y, Jin J, Zhao Q, Pan Z, Wu M, Shu HB, Dong C and Zhong B: BInduction of USP25 by viral infection promotes innate antiviral responses by mediating the stabilization of TRAF3 and TRAF6. Proc Natl Acad Sci USA. 112:11324–11329. 2015. View Article : Google Scholar : PubMed/NCBI

28 

Cheng L, Chen J, Fu Q, He S, Li H, Liu Z, Tan G, Tao Z, Wang D, Wen W, et al: Chinese society of allergy guidelines for diagnosis and treatment of allergic rhinitis. Allergy Asthma Immunol Res. 10:300–353. 2018. View Article : Google Scholar : PubMed/NCBI

29 

Chen M, Wu Y, Yuan S, Tang M, Zhang L, Chen J, Li L, Wu J, Zhang J and Yin Y: Allergic rhinitis improvement in asthmatic children after using acaricidal bait: A randomized, double-blind, cross-placebo study. Front Pediatr. 9:7091392021. View Article : Google Scholar : PubMed/NCBI

30 

Deng YQ, Yang YQ, Wang SB, Li F, Liu MZ, Hua QQ and Tao ZZ: Intranasal administration of lentiviral miR-135a regulates mast cell and allergen-induced inflammation by targeting GATA-3. PLoS One. 10:e01393222015. View Article : Google Scholar : PubMed/NCBI

31 

Xiang R, Xu Y, Zhang W, Kong YG, Tan L, Chen SM, Deng YQ and Tao ZZ: Semaphorin 3A inhibits allergic inflammation by regulating immune responses in a mouse model of allergic rhinitis. Int Forum Allergy Rhinol. 9:528–537. 2019. View Article : Google Scholar : PubMed/NCBI

32 

Patel NN, Kohanski MA, Maina IW, Workman AD, Herbert DBR and Cohen NA: Sentinels at the wall: Epithelial-derived cytokines serve as triggers of upper airway type 2 inflammation. Int Forum Allergy Rhinol. 9:93–99. 2019. View Article : Google Scholar : PubMed/NCBI

33 

Papazian D, Hansen S and Würtzen PA: Airway responses towards allergens-from the airway epithelium to T cells. Clin Exp Allergy. 45:1268–1287. 2015. View Article : Google Scholar : PubMed/NCBI

34 

Cianferoni A and Spergel J: The importance of TSLP in allergic disease and its role as a potential therapeutic target. Expert Rev Clin Immunol. 10:1463–1474. 2014. View Article : Google Scholar : PubMed/NCBI

35 

Pan Z, Zhou Y, Luo X, Ruan Y, Zhou L, Wang Q, Yan YJ, Liu Q and Chen J: Against NF-κB/thymic stromal lymphopoietin signaling pathway, catechin alleviates the inflammation in allergic rhinitis. Int Immunopharmacol. 61:241–248. 2018. View Article : Google Scholar : PubMed/NCBI

36 

Kumagai A, Kubo T, Kawata K, Kamekura R, Yamashita K, Jitsukawa S, Nagaya T, Sumikawa Y, Himi T, Yamashita T and Ichimiya S: Keratinocytes in atopic dermatitis express abundant ΔNp73 regulating thymic stromal lymphopoietin production via NF-Κb. J Dermatol Sci. 88:175–183. 2017. View Article : Google Scholar : PubMed/NCBI

37 

Lee HC and Ziegler SF: Inducible expression of the proallergic cytokine thymic stromal lymphopoietin in airway epithelial cells is controlled by NFkappaB. Proc Natl Acad Sci USA. 104:914–919. 2007. View Article : Google Scholar : PubMed/NCBI

38 

Cultrone A, de Wouters T, Lakhdari O, Kelly D, Mulder I, Logan E, Lapaque N, Doré J and Blottière HM: The NF-κB binding site located in the proximal region of the TSLP promoter is critical for TSLP modulation in human intestinal epithelial cells. Eur J Immunol. 43:1053–1062. 2013. View Article : Google Scholar : PubMed/NCBI

39 

Harhaj EW and Dixit VM: Regulation of NF-κB by deubiquitinases. Immunol Rev. 246:107–124. 2012. View Article : Google Scholar : PubMed/NCBI

40 

Aksentijevich I and Zhou Q: NF-κB pathway in autoinflammatory diseases: Dysregulation of protein modifications by ubiquitin defines a new category of autoinflammatory diseases. Front Immunol. 8:3992017. View Article : Google Scholar : PubMed/NCBI

41 

Shi JH and Sun SC: Tumor necrosis factor receptor-associated factor regulation of nuclear factor κB and mitogen-activated protein kinase pathways. Front Immunol. 9:18492018. View Article : Google Scholar : PubMed/NCBI

42 

Häcker H, Tseng PH and Karin M: Expanding TRAF function: TRAF3 as a tri-faced immune regulator. Nat Rev Immunol. 11l:457–468. 2011. View Article : Google Scholar : PubMed/NCBI

43 

He JQ, Saha SK, Kang JR, Zarnegar B and Cheng G: Specificity of TRAF3 in its negative regulation of the noncanonical NF-kappa B pathway. J Biol Chem. 282:3688–3694. 2007. View Article : Google Scholar : PubMed/NCBI

44 

Cildir G, Low KC and Tergaonkar V: Noncanonical NF-κB signaling in health and disease. Trends Mol Med. 22:414–429. 2016. View Article : Google Scholar : PubMed/NCBI

45 

Zarnegar B, Yamazaki S, He JQ and Cheng G: Control of canonical NF-kappaB activation through the NIK-IKK complex pathway. Proc Natl Acad Sci USA. 105:3503–3508. 2008. View Article : Google Scholar : PubMed/NCBI

46 

Eden K, Rothschild DE, McDaniel DK, Heid B and Allen IC: Noncanonical NF-κB signaling and the essential kinase NIK modulate crucial features associated with eosinophilic esophagitis pathogenesis. Dis Model Mech. 10:1517–1527. 2017. View Article : Google Scholar : PubMed/NCBI

47 

Wen J, Bai H, Chen N, Zhang W, Zhu X, Li P and Gong J: USP25 promotes endotoxin tolerance via suppressing K48-linked ubiquitination and degradation of TRAF3 in Kupffer cells. Mol Immunol. 106:53–62. 2019. View Article : Google Scholar : PubMed/NCBI

48 

Zhong B, Liu X, Wang X, Chang SH, Liu X, Wang A, Reynolds JM and Dong C: Negative regulation of IL-17-mediated signaling and inflammation by the ubiquitin-specific protease USP25. Nat Immunol. 13:1110–1117. 2012. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Chang W, Lv H, Tan L, Gao Z, Liu P, Qin D, Zhang W and Xu Y: Downregulation of deubiquitinating enzyme USP25 promotes the development of allergic rhinitis by enhancing TSLP signaling in the nasal epithelium. Mol Med Rep 26: 347, 2022.
APA
Chang, W., Lv, H., Tan, L., Gao, Z., Liu, P., Qin, D. ... Xu, Y. (2022). Downregulation of deubiquitinating enzyme USP25 promotes the development of allergic rhinitis by enhancing TSLP signaling in the nasal epithelium. Molecular Medicine Reports, 26, 347. https://doi.org/10.3892/mmr.2022.12863
MLA
Chang, W., Lv, H., Tan, L., Gao, Z., Liu, P., Qin, D., Zhang, W., Xu, Y."Downregulation of deubiquitinating enzyme USP25 promotes the development of allergic rhinitis by enhancing TSLP signaling in the nasal epithelium". Molecular Medicine Reports 26.5 (2022): 347.
Chicago
Chang, W., Lv, H., Tan, L., Gao, Z., Liu, P., Qin, D., Zhang, W., Xu, Y."Downregulation of deubiquitinating enzyme USP25 promotes the development of allergic rhinitis by enhancing TSLP signaling in the nasal epithelium". Molecular Medicine Reports 26, no. 5 (2022): 347. https://doi.org/10.3892/mmr.2022.12863
Copy and paste a formatted citation
x
Spandidos Publications style
Chang W, Lv H, Tan L, Gao Z, Liu P, Qin D, Zhang W and Xu Y: Downregulation of deubiquitinating enzyme USP25 promotes the development of allergic rhinitis by enhancing TSLP signaling in the nasal epithelium. Mol Med Rep 26: 347, 2022.
APA
Chang, W., Lv, H., Tan, L., Gao, Z., Liu, P., Qin, D. ... Xu, Y. (2022). Downregulation of deubiquitinating enzyme USP25 promotes the development of allergic rhinitis by enhancing TSLP signaling in the nasal epithelium. Molecular Medicine Reports, 26, 347. https://doi.org/10.3892/mmr.2022.12863
MLA
Chang, W., Lv, H., Tan, L., Gao, Z., Liu, P., Qin, D., Zhang, W., Xu, Y."Downregulation of deubiquitinating enzyme USP25 promotes the development of allergic rhinitis by enhancing TSLP signaling in the nasal epithelium". Molecular Medicine Reports 26.5 (2022): 347.
Chicago
Chang, W., Lv, H., Tan, L., Gao, Z., Liu, P., Qin, D., Zhang, W., Xu, Y."Downregulation of deubiquitinating enzyme USP25 promotes the development of allergic rhinitis by enhancing TSLP signaling in the nasal epithelium". Molecular Medicine Reports 26, no. 5 (2022): 347. https://doi.org/10.3892/mmr.2022.12863
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team